Comparison of subacromial Ketorolac, betamethazone LA and triamcinolon injection in treatment of impingement syndrome
Phase 2
- Conditions
- Impingement syndrome of shoulder.Impingement syndrome of shoulder
- Registration Number
- IRCT2017042927797N2
- Lead Sponsor
- Vice Chancellor of Reaserch and Technology, Babol University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 105
Inclusion Criteria
all people with shoulder pain referred to orthopedic clinics and diagnostic imaging in the diagnosis of shoulder impingement syndrome has been laid for them and their consent to participate in the study. Exclusion criteria: patients with all of the diagnosis except impingement syndrome; Do not go to the next follow up; do not have a history of shoulder dislocation or fracture or a systemic disease that affects the joint and soft tissue .
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Determine the function of the patient. Timepoint: Before injection, weeks 2, 4 and 6 after injection. Method of measurement: By Oxford Shoulder Score questionnaire.;Patient pain severity. Timepoint: Before injection, weeks 2, 4 and 6 after injection. Method of measurement: By Visual Analogus Scale questionnaire.
- Secondary Outcome Measures
Name Time Method Tendon Rupture. Timepoint: weeks 2, 4 and 6 after injection. Method of measurement: Physical Examination.;Injection site infection. Timepoint: weeks 2, 4 and 6 after injection. Method of measurement: Observation.